Jane Street’s Sana Biotechnology SANA Stock Holding History

Jane Street’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$125K	Buy	35,900 +15,200	+73%	+$49K	﹤0.01%	10468
2026 Q1	$59.6K	Buy	20,700 +2,900	+16%	+$11.4K	﹤0.01%	10901
2025 Q4	$72.4K	Sell	17,800 -700	-4%	-$3.13K	﹤0.01%	10352
2025 Q3	$65.7K	Sell	18,500 -8,400	-31%	-$30.4K	﹤0.01%	10272
2025 Q2	$73.4K	Buy	26,900 +2,200	+9%	+$4.54K	﹤0.01%	9075
2025 Q1	$41.5K	Buy	+24,700	New	+$69K	﹤0.01%	9043
2024 Q2	–	Sell	-40,000	Closed	-$400K	–	10095
2024 Q1	$400K	Buy	+40,000	New	+$300K	﹤0.01%	7089
2023 Q3	–	Sell	-173,300	Closed	-$1.03M	–	9282
2023 Q2	$1.03M	Buy	+173,300	New	+$999K	﹤0.01%	5140
2022 Q3	–	Sell	-11,300	Closed	-$73K	–	10364
2022 Q2	$73K	Buy	+11,300	New	+$72K	﹤0.01%	8797
2022 Q1	–	Sell	-12,900	Closed	-$200K	–	10937
2021 Q4	$200K	Sell	12,900 -300	-2%	-$5.78K	﹤0.01%	8817
2021 Q3	$297K	Buy	+13,200	New	+$277K	﹤0.01%	8205

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Jane Street's SANA Position: Q2 2026 in Review

Jane Street sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 132,715 shares — an estimated $428K sold.

Jane Street first reported a position in SANA in Q2 2022 and held it in 15 quarters. The position peaked at $2.72M in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Jane Street reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
Jane Street sold 132,715 Sana Biotechnology shares in Q2 2026, an estimated $428K.
Jane Street first reported a position in Sana Biotechnology in Q2 2022 and held it in 15 quarters.
Jane Street's Sana Biotechnology position peaked at $2.72M in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.